1,3-双(2-氯乙基)-1-亚硝基脲（NSC-409962）与甲氨蝶呤（NSC-740）联合治疗晚期小鼠白血病L1210 - Suppr | 超能文献

1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.

作者信息

Venditti J M, Kline I, Tyrer D D, Goldin A

出版信息

Cancer Chemother Rep. 1965 Oct;48:35-9.

Abstract

摘要

相似文献

1

1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and methotrexate (NSC-740) as combination therapy for advanced mouse leukemia L1210.1,3-双(2-氯乙基)-1-亚硝基脲（NSC-409962）与甲氨蝶呤（NSC-740）联合治疗晚期小鼠白血病L1210

Cancer Chemother Rep. 1965 Oct;48:35-9.

2

Effect of combined therapy with cytosine arabinoside (NSC-63878) and l,3-bis-(2-chloroethyl)-1-nitrosourea (NSC-409962) on sarcoma 180 and L1210 in vivo.阿糖胞苷（NSC - 63878）与1,3 - 双（2 - 氯乙基）- 1 - 亚硝基脲（NSC - 409962）联合治疗对体内肉瘤180和L1210的影响。

Cancer Chemother Rep. 1969 Sep;53(4):215-21.

3

Separate and sequential chemotherapy of mouse leukemia L1210 with 1-beta-D-arabinofuranosylcytosine hydrochloride and 1,3-bis(2-chloroethyl)-1-nitrosourea.用盐酸1-β-D-阿拉伯呋喃糖基胞嘧啶和1,3-双(2-氯乙基)-1-亚硝基脲对小鼠白血病L1210进行单独和序贯化疗。

Cancer Res. 1967 May;27(5):873-9.

4

Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).阿糖胞苷（NSC - 63878）加5 -（3,3 - 二甲基 - 1 - 三氮烯）咪唑 - 4 - 甲酰胺（NSC - 45388）疗法在晚期小鼠L1210白血病中的价值以及与甲氨蝶呤（NSC - 740）或1,3 - 双（2 - 氯乙基）-1 - 亚硝基脲（卡莫司汀；NSC - 409962）序贯剂量联合使用时疗效的增强。

Cancer Chemother Rep. 1973 Sep-Oct;57(3):291-8.

5

Effect of treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or cyclophosphamide on spleen colony-forming units and survival time of leukemic mice.1,3-双（2-氯乙基）-1-亚硝基脲或环磷酰胺治疗对白血病小鼠脾集落形成单位和存活时间的影响。

Cancer Res. 1968 Jul;28(7):1242-9.

6

Criteria associated with destruction of leukemia and solid tumor cells in animals.与动物体内白血病和实体瘤细胞破坏相关的标准。

Cancer Res. 1967 Dec;27(12):2636-45.

7

Effects of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) and its degradation products on progression of L1210 cells through the cell cycle.

Cancer Chemother Rep. 1971 Jun;55(3):215-20.

8

Effect of 1,3-bis(2-chloroethyl)-1-nitrosourea (NSC-409962) and cyclophosphamide (NSC-26271) on nicotinamide adenine dinucleotide glycohydrolase in normal and leukemic mouse tissues.1,3-双（2-氯乙基）-1-亚硝基脲（NSC-409962）和环磷酰胺（NSC-26271）对正常及白血病小鼠组织中烟酰胺腺嘌呤二核苷酸糖水解酶的影响

Cancer Chemother Rep. 1968 Sep;52(5):569-78.

9

Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosourea by vitamin A and caffeine.

J Natl Cancer Inst. 1972 Apr;48(4):927-32.

10

1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) given concomitantly with cytosine arabinoside (NSC-63878) in the treatment of cancer.

Cancer Chemother Rep. 1970 Oct;54(5):347-59.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。